Biotech firms develop drugs from living organisms; pharma from chemicals. Biotech products require a Biologics License Application for FDA approval. Investing focus should be on the long-term ...

Driving revenue growth and earnings growth are two different things.

Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking ...

Mergers and acquisitions (M&A) activity across pharmaceutical and biotech sectors has accelerated significantly in 2026, extending the strong recovery that began in 2025. A recent surge in dealmaking ...

Built and backed by learning company Wayground, Skillet emerges from stealth with AI roleplay, manager coaching, and ...

Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the ...

This Biotech Stock Is Up 85%. FDA Has Agreed to Review a Skin Cancer Drug. Replimune has twice sought regulatory approval for its experimental melanoma drug, citing an unmet need for advanced ...

Michel Lagarde becomes West Pharmaceutical Services CEO on August 31. West Pharmaceutical Services has appointed Michel ...

According to a new study by Wissen Research, the global sustainable pharmaceutical packaging market is projected to expand from USD 114.5 billion in 2025 to USD 270.4 billion by 2031, registering a ...

Teva's transformation is gaining momentum.

ABU DHABI, 11th June May, 2026 (WAM) -- ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer distinguished as the nation’s first producer of oncology and hormone products, has announced a ...